Inside This Issue of JACC  by unknown
I
Jnside This Issue of JACC
ULY 4, 2006, VOLUME 48, NO. 1Clinical Trial
Oral MMP Inhibitor Fails to Protect Against LV Remodeling
Matrixmetallproteinases (MMPs) are proteolytic enzymes that degrade the extra-cellular membrance (ECM) that provides the scaffolding for cardiac myocytes.
Enhanced activity of these enzymes has been associated with left ventricular (LV)
remodeling and progressive heart failure. PG-116800 is an oral MMP inhibitor
developed for use in patients with arthritis. The PREMIER (Prevention ofMyocardial
Infarction Early Remodeling) trial randomized patients within 48 h of an ST-segment
elevation myocardial infarction to either PG-116800 or placebo. There was no differ-
ence in the primary end point of LV end-diastolic volume 90 days later. Other efficacy
end points also suggested no benefit to MMP inhibition. Whereas inhibiting break-
down of the ECM appears to be beneficial in animal models, there is no evidence of
clinical utility for this drug in preventing LV remodeling in humans. See page 15.
Interventional Cardiology
Mandatory Angiographic Follow-Up Increases TVR by 40%
The fact that most trials comparing drug-eluting stents (DES) with bare-metalstents (BMS) required angiographic follow-up at 9 months has raised concern
that the clinical benefit of DES may be overestimated as a result of the “oculostenotic
reflex.” Pinto and colleagues used data from the TAXUS-IV trial, which randomized
patients to either a paclitaxel-eluting stents (PES) or BMS. In this trial, the first 500
patients had protocol-mandated angiographic follow-up at 9 months, whereas the
other subjects were followed for clinical events only. Those assigned to angiographic
follow-up were nearly 40% more likely to undergo target vessel revascularization
(TVR) than those assigned to clinical follow-up. The increases were similar for both
BMS and PES groups such that PES reduced TVR by60% regardless of follow-up.
The authors conclude that future studies designed to determine the true clinical
benefits of DES should either forgo routine angiographic follow-up or separate the
time of repeat angiography from the primary clinical end point by as long as possible.
See page 32.
Page 52
Coronary Artery Disease
Understanding the Hemodynamics of Collateral Circulation
Twoarticles and an editorial in this issue use coronary pressurewires tomeasure thecomplex hemodynamics involved in collateral recruitment and de-recruitment.
In the first paper by Werner and colleagues, adenosine infusion produced coronary
steal in about one-half of patients with chronic total occlusions (CTOs). Those who
demonstrated steal had either an atherosclerotic lesion in the donor artery or reduced
vasodilatory capacity in the microcirculation. Zimarino and colleagues studied the
timing of “de-recruitment” of collateral circuits after the opening of CTOs. They
measured flow through collateral arteries before and after opening a CTO; they then
stimulated restenosis 10 and 20 min later with balloon inflations and assessed chest
pain and ST-segment changes. Flow through the coronaries was found to be substan-
tially reduced after only 10 min, and further reduced over time, suggesting that these
patients will be more susceptible to angina should the vessel reocclude. An editorial by
Morton Kern places these findings in historical perspective. See pages 51, 59, and
66. See figure.
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Heart Rhythm Disorders
T-Wave Alternans Screening Improves Cost Effectiveness for ICDs
Implantable cardioverter-defibrillators (ICDs) have been shown topreventmortalityin patients with ischemic cardiomyopathy; some estimates have suggested that
implanting an ICD in every eligible patient would cost more than $2.5 billion/year.
Microvolt T-wave alternans (MTWA) testing may be useful in stratifying the subse-
quent risk of sudden cardiac death,with some studies suggesting that the risk of sudden
cardiac death is 2 times higher in those with non-negative MTWA. Chan and
colleagues created a Markov model that allows the comparison of several variables
regarding efficacy and cost to determine the optimal strategy for identifying who
should receive an ICD. In this model, providing ICDs only to those whose MTWA
was non-negative resulted in an incremental cost-effectiveness ratio (ICER) of
$48,700/quality-adjusted life-year over medical therapy. Placing ICDs in all patients
would result in an ICER of $88,700/quality-adjusted life-year, compared to MTWA
testing first. This study suggests that risk stratification with MTWA testing in
MADIT-II eligible patients improves the cost-effectiveness of ICDs. See page 112.
See figure.
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Cardiac Imaging
Delayed Enhancement MSCT Accurately Measures Infarct Size
Delayed enhancement magnetic resonance imaging (DE-MRI) is now the goldstandard formeasuring infarct size in living animals. This technique relies on the
fact that gadolinium contrast can accumulate in areas of increased extracellular fluid;
iodinated contrast behaves in a similar fashion, but the imaging quality of computed
tomographyhas lacked the spatial and temporal resolutionuntil the recent deployment
of multi-slice computed tomography (MSCT). Researchers at the Thoraxcenter cre-
ated controlled infarctions in 14 pigs; approximately 5 days later, they sequentially
performed DE-MRI and DE-MSCT. The hearts were then excised and stained with
triphenyltetrazolium chloride for pathologic staining. There was excellent correlation
among all 3 techniques. This study suggests that DE-MSCT may be as accurate as
DE-MRI for infarct sizing/detection, although the optimal timeframe andprotocol for
DE-MSCT requires further study. See page 144. See figure.
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Cardiac Imaging
Adenosine Infusion Allows Assessment of Perfusion with MDCT
Multi-detector computed tomography (MDCT) has been shown to accuratelyclassify coronary lesions as or 50%, but lacks the ability to assess myocar-
dial perfusion in territories distal to these segments or the severity of obstruction in
heavily calcified segments. George and colleagues measured the signal intensity of
myocardial contrast in segments before and after the infusion of adenosine in a canine
model of coronary stenosis and compared these measurements with microsphere
infusions. There was a significant and linear relationship between myocardial blood
flow and tissue signal density. This study suggests that adding an assessment of
myocardial blood flow during hyperemia may allow for physiologic assessment of
coronary stenoses. See page 153. See figure.
